Celldex Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Celldex Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Celldex Therapeutics Inc Strategy Report
- Understand Celldex Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Celldex Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20240117057A1 | Application | Anti-kit antibodies and uses thereof | A61P17/00; C07K16/2866; C07K2317/52; C07K2317/76 | April 11, 2024 |
US20240109961A1 | Application | Treatment of chronic prurigo | A61K2039/505; A61P17/04; C07K16/2803; C07K2317/52 | April 04, 2024 |
EP4320159A1 | Application | Antikörper gegen ilt4, bispezifische anti-ilt4/pd-l1-antikörper und verwendungen davon | C07K16/2803; C07K16/2827; C07K2317/24; C07K2317/31; C07K2317/33; C07K2317/35; C07K2317/52; C07K2317/60; C07K2317/622; C07K2317/70; C07K2317/76; C07K2317/92 | February 14, 2024 |
US11891452B2 | Grant | Anti-kit antibodies and uses thereof | A61K2039/505; A61K31/4045; A61K31/506; A61K38/19; A61K39/39533; A61K39/3955; A61K39/39558; A61K45/06; A61K47/6851; C07K16/2803; C07K16/32; C07K16/40; C07K2317/14; C07K2317/21; C07K2317/24; C07K2317/31; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/77; C07K2317/92; C12Y207/10001; G01N2333/70596; G01N2333/91205; G01N33/566; G01N33/5748 | February 06, 2024 |
WO2024026355A1 | Application | Anti-kit antibody formulations and methods | A61K39/395; A61K47/02; A61K47/12; A61K47/183; A61K47/26; A61K9/0019; C07K16/28 | February 01, 2024 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer